The impact of glucagon-like peptide-1 agonists on MGUS progression in patients with type 2 diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
SkylineDx, innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results